NL-OMON35106撤回不适用
The role of the endocannabinoid system in Attention-Deficit/Hyperactivity Disorder and symptoms: a pharmacological fMRI study - THC phMRI in ADHD patients
niversitair Medisch Centrum Utrecht0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* Diagnosed with ADHD (DSM-IV criteria)
- •* History of mild cannabis use for at least one year (less than once/wek and more than 4 times / year)
- •* Right-handedness, assessed with the Edinburgh Handedness Inventory
- •* Written informed consent of the participant
排除标准
- •* Any clinical significant abnormality of any clinical laboratory test, except for the predetermined psychiatric disorder, i.e. ADHD, including urinary screening
- •* Impaired physical health evaluated by medical history, physical (including neurological) examination and screening laboratory tests (see par 8.3.1.)
- •* history of alcohol and /or drug abuse (DSM-IV criteria)
- •* Body Mass Index (B.M.I) < 18 kg/m2 or > 28 kg/m2
- •* any subject who received any investigational medication within 90 days prior to the start of the study or who is scheduled to receive an investigational drug
- •* use of any medication within three weeks prior to the start of the study, except for paracetamol and medication for ADHD and related symptoms
- •* contra-indications for MRI (claustrophobia, metal objects in body (e.g. braces, pacemakers, metal clips)
研究者
相似试验
已完成
不适用
The Role of the Endocannabinoid System in Psychiatric Disorders and Symptoms: a Pharmacological fMRI studysmoking10037176addictionNL-OMON33616niversitair Medisch Centrum Utrecht48
进行中（未招募）
不适用
The Role of the Endocannabinoid System in Psychiatric Disorders and Symptoms: a Pharmacological fMRI study - THC-phMRI in patientsTHis research project will be performed with patients with a psychiatric disorder in order to determine whether the endocannabinoid system is altered in psychiatric diseases. Psychistric disorders that are investigated are schizophrenia, depression, ADHD, OCD and addiction. Patients will be compared with healthy controls.MedDRA version: 9.1Level: SOCClassification code 10037175Term: Psychiatric disordersMedDRA version: 9.1Level: LLTClassification code 10051623Term: CannabinoidsEUCTR2007-004247-30-NLniversity Medical Center Utrecht
已完成
不适用
Investigation of the role of the cannabinoid system in mediating alcohol cue-induced Nucleus accumbens response in individuals with alcohol Use disorder using functional magnetic resonance imagingAlcohol Use Disorder (DSM-5)DRKS00029993Zentralinstitut für Seelische Gesundheit Klinik für Abhängiges Verhalten und Suchtmedizin28
已完成
不适用
The Role of the Endocannabinoid System in Sweet Taste Intensity and LikingObesityNL-OMON40528Wageningen Universiteit36
已完成
不适用
The role of the endocannabinoidsystem and the immune system in chronic pain - alterations in comparison to healthy volunteers and influence of pain treatmentR52.2Other chronic painDRKS00005954Interdisziplinäre Schmerzambulanz und Tageskinik, LMU München, Klinikum Großhadern98